PolyPid Ltd. (PYPD)
NASDAQ·Healthcare·Biotechnology
$5.75
+8.60%
Mkt Cap $42.60M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$12.50
Range $12.00 – $13.00
Implied Upside
+117.6%
Consensus $12.50 vs current $5.75
NASDAQ·Healthcare·Biotechnology
$5.75
+8.60%
Mkt Cap $42.60M
No recent rating data.
Price Target (4 analysts)
$12.50
Range $12.00 – $13.00
+117.6%
Consensus $12.50 vs current $5.75